175 related articles for article (PubMed ID: 30678968)
1. Optimization of ionic liquid-incorporated PLGA nanoparticles for treatment of biofilm infections.
Takahashi C; Hattori Y; Yagi S; Murai T; Takai C; Ogawa N; Tanemura M; Fuji M; Kawashima Y; Yamamoto H
Mater Sci Eng C Mater Biol Appl; 2019 Apr; 97():78-83. PubMed ID: 30678968
[TBL] [Abstract][Full Text] [Related]
2. Observation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquid.
Takahashi C; Ogawa N; Kawashima Y; Yamamoto H
Microscopy (Oxf); 2015 Jun; 64(3):169-80. PubMed ID: 25757698
[TBL] [Abstract][Full Text] [Related]
3. A microscopy method for scanning transmission electron microscopy imaging of the antibacterial activity of polymeric nanoparticles on a biofilm with an ionic liquid.
Takahashi C; Muto S; Yamamoto H
J Biomed Mater Res B Appl Biomater; 2017 Aug; 105(6):1432-1437. PubMed ID: 27086715
[TBL] [Abstract][Full Text] [Related]
4. Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm.
Iannitelli A; Grande R; Di Stefano A; Di Giulio M; Sozio P; Bessa LJ; Laserra S; Paolini C; Protasi F; Cellini L
Int J Mol Sci; 2011; 12(8):5039-51. PubMed ID: 21954343
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation of Red Propolis in Polymer Nanoparticles for the Destruction of Pathogenic Biofilms.
de Mélo Silva IS; do Amorim Costa Gaspar LM; Rocha AMO; da Costa LP; Tada DB; Franceschi E; Padilha FF
AAPS PharmSciTech; 2020 Jan; 21(2):49. PubMed ID: 31900606
[TBL] [Abstract][Full Text] [Related]
6. Antibacterial efficacy of inhalable antibiotic-encapsulated biodegradable polymeric nanoparticles against E. coli biofilm cells.
Cheow WS; Chang MW; Hadinoto K
J Biomed Nanotechnol; 2010 Aug; 6(4):391-403. PubMed ID: 21323113
[TBL] [Abstract][Full Text] [Related]
7. Morphological study of efficacy of clarithromycin-loaded nanocarriers for treatment of biofilm infection disease.
Takahashi C; Akachi Y; Ogawa N; Moriguchi K; Asaka T; Tanemura M; Kawashima Y; Yamamoto H
Med Mol Morphol; 2017 Mar; 50(1):9-16. PubMed ID: 27119723
[TBL] [Abstract][Full Text] [Related]
8. PEI/NONOates-doped PLGA nanoparticles for eradicating methicillin-resistant Staphylococcus aureus biofilm in diabetic wounds via binding to the biofilm matrix.
Hasan N; Cao J; Lee J; Naeem M; Hlaing SP; Kim J; Jung Y; Lee BL; Yoo JW
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109741. PubMed ID: 31349480
[TBL] [Abstract][Full Text] [Related]
9. Visualization of silver-decorated poly (DL-lactide-co-glycolide) nanoparticles and their efficacy against Staphylococcus epidermidis.
Takahashi C; Matsubara N; Akachi Y; Ogawa N; Kalita G; Asaka T; Tanemura M; Kawashima Y; Yamamoto H
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():143-149. PubMed ID: 28024570
[TBL] [Abstract][Full Text] [Related]
10. Targeted delivery of rifaximin using P6.2-decorated bifunctional PLGA nanoparticles for combating Staphylococcus aureus infections.
Arayici PP; Coksu I; Ozbek T; Acar S
Biomater Adv; 2024 Jul; 161():213862. PubMed ID: 38678666
[TBL] [Abstract][Full Text] [Related]
11. Preparation of PLGA-chitosan based nanocarriers for enhancing antibacterial effect of ciprofloxacin in root canal infection.
Arafa MG; Mousa HA; Afifi NN
Drug Deliv; 2020 Dec; 27(1):26-39. PubMed ID: 31833443
[TBL] [Abstract][Full Text] [Related]
12. Formulation development and in vitro evaluation of gentamicin sulfate-loaded PLGA nanoparticles based film for the treatment of surgical site infection by Box-Behnken design.
Dhal C; Mishra R
Drug Dev Ind Pharm; 2019 May; 45(5):805-818. PubMed ID: 30698993
[TBL] [Abstract][Full Text] [Related]
13. Peptide-modified nanoparticles inhibit formation of
Kalia P; Jain A; Radha Krishnan R; Demuth DR; Steinbach-Rankins JM
Int J Nanomedicine; 2017; 12():4553-4562. PubMed ID: 28790818
[TBL] [Abstract][Full Text] [Related]
14. Preparation, in vitro release and antibacterial activity evaluation of rifampicin and moxifloxacin-loaded poly(D,L-lactide-co-glycolide) microspheres.
Qiao Z; Yuan Z; Zhang W; Wei D; Hu N
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):790-798. PubMed ID: 30892092
[TBL] [Abstract][Full Text] [Related]
15. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
[TBL] [Abstract][Full Text] [Related]
16. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.
Patel BK; Parikh RH; Patel N
Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405
[TBL] [Abstract][Full Text] [Related]
17. Development of ionic liquid-coated PLGA nanoparticles for applications in intravenous drug delivery.
Hamadani CM; Dasanayake GS; Gorniak ME; Pride MC; Monroe W; Chism CM; Heintz R; Jarrett E; Singh G; Edgecomb SX; Tanner EEL
Nat Protoc; 2023 Aug; 18(8):2509-2557. PubMed ID: 37468651
[TBL] [Abstract][Full Text] [Related]
18. PLGA nanoparticle-encapsulated lysostaphin for the treatment of Staphylococcus aureus infections.
Landa G; Aguerri L; Irusta S; Mendoza G; Arruebo M
Int J Biol Macromol; 2024 Jun; 271(Pt 1):132563. PubMed ID: 38782313
[TBL] [Abstract][Full Text] [Related]
19. Platensimycin-Encapsulated Poly(lactic-
Liu X; Wang Z; Feng X; Bai E; Xiong Y; Zhu X; Shen B; Duan Y; Huang Y
Bioconjug Chem; 2020 May; 31(5):1425-1437. PubMed ID: 32286051
[TBL] [Abstract][Full Text] [Related]
20. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
Mahmoud MY; Demuth DR; Steinbach-Rankins JM
J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
